Concepedia

Megan M. Emori

MM

4

Publications

306

Citations

4

H-Index

2015

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Megan M. Emori is an author at Dana-Farber Cancer Institute specializing in medicine, cancer research, and oncology.

Top concepts

Publications per year

2015–2016

4

Publications

4

GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract

Brooke E. Howitt, Megan M. Emori, Ronny Drapkin et al. · The American Journal of Surgical Pathology · 2015 · 154 citations

, , +11

Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research

Kevin M. Elias, Megan M. Emori, Eniko Papp et al. · Gynecologic Oncology · 2015 · 78 citations · Full text

, , +12

Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors

Kevin M. Elias, Megan M. Emori, Thomas Westerling et al. · JCI Insight · 2016 · 49 citations · Full text

Granulin, a novel STAT3-interacting protein, enhances STAT3 transcriptional function and correlates with poorer prognosis in breast cancer

Jennifer Yeh, Simion Kreimer, Sarah R. Walker et al. · Genes & Cancer · 2015 · 25 citations · Full text

, , +20

Rows per page

1–4 of 4